Oragenics, Inc.OGENNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-12.5%
5Y CAGR-7.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-12.5%/yr
vs +23.8%/yr prior
5Y CAGR
-7.8%/yr
Recent deceleration
Acceleration
-36.3pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $10.56M | -49.5% |
| 2023 | $20.90M | +45.0% |
| 2022 | $14.42M | -8.6% |
| 2021 | $15.77M | +247.8% |
| 2020 | $4.53M | -71.4% |
| 2019 | $15.88M | +58.9% |
| 2018 | $9.99M | +48.8% |
| 2017 | $6.72M | -21.4% |
| 2016 | $8.54M | -30.8% |
| 2015 | $12.35M | - |